The legal battle over who can make and distribute a weight loss ingredient is brewing, and an Edmond telehealth provider is ...

Telehealth providers, whose revenue skyrocketed amidst GLP-1 shortages, remain defiant on their compounded semaglutide ...

A Kentucky doctor faces up to three years in prison after admitting he sold patients a non-approved weight-loss drug. Matthew ...

People are buying semaglutide and tirzepatide, the key ingredients in Ozempic and Zepbound, from unconventional sources. Doctors have safety concerns.

Novo Nordisk, the maker of Ozempic and Wegovy, has also jumped into the legal fight —this time by intervening in the OFA’s lawsuit against the FDA. The company supports the agency’s move to restrict ...

Some celebrities who have spoken out about using the weight loss drug include Oprah Winfrey, Kelly Clarkson, and James Corden ...

ASHLAND A local family physician and former Ashland School Board member pleaded guilty on Tuesday to federal charges related to the unlawful distribution of weight loss drugs on the heels of his ...

An Ashland physician and owner of Lewis Family Care, Matthew Lewis, 44, has pleaded guilty at U.S. District Court in Ashland ...

Detailed price information for Hims & Hers Health Inc (HIMS-N) from The Globe and Mail including charting and trades.

Some strengths of these drugs were first added to FDA’s Drug Shortages list in March 2022 (Wegovy®) and August 2022 (Ozempic®). On February 21, 2025, semaglutide was taken off the shortage list.

Physicians are turning to other options, including older, cheaper medications, as compounding GLP-1s comes to an end.